Navigation Links
TrialNetworks Customer to Present Results of Using Site Engagement Technology to Improve Study Operations and Patient Enrollment at Clinical Trial Optimization Conference
Date:9/27/2013

Needham, MA (PRWEB) September 27, 2013

TrialNetworks, an innovative technology company which provides the global pharmaceutical industry’s only Clinical Trial Optimization System, will sponsor and actively participate in the following prominent and collaborative events next month:

At Clinical Trial Optimization, a top-10 pharmaceutical company will present findings on using TrialNetworks technology to improve patient enrollment and trial execution in a global study. The TrialNetworks system is used by study sponsors from small biotechs to large global pharmas to optimize operations from startup through closeout – including feasibility, site activation, patient recruitment and retention, site engagement, trial conduct, online training, document management and more – all integrated within one centralized cloud-based platform.

Eric Silberstein, TrialNetworks CEO, said, “Our team is comprised of expert technologists with a deep understanding and appreciation of clinical research, and former study practitioners who are passionate about using technology to improve trial operations. We place tremendous value on sponsoring industry conferences because they provide an ideal opportunity to build strong relationships with key opinion leaders and learn about the evolving challenges our customers face.”

About TrialNetworks
TrialNetworks provides sponsors and CROs the industry's only Clinical Trial Optimization System. Using modern and intuitive technology, the TrialNetworks platform increases the quality and efficiency of clinical operations at each stage of a trial from feasibility through closeout. TrialNetworks apps, including Checklist, Document Library, Visit Guide, Action Items and Directory, are available in a unified and secure cloud-based interface. Customers ranging from Top 10 pharmaceutical companies to biotechs have implemented the TrialNetworks platform for use in Phase I-IV studies by more than 20,000 site staff in 60 countries. To learn why sponsors rely on TrialNetworks to optimize clinical trial operations, request a personalized demo at http://www.trialnetworks.com.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11169647.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Customer Satisfaction, A key to Success: Narang Medical Limited
2. TAKE Solutions Brings Together Leading Experts and TAKE Customers at “Converge 2012” to Discuss Business
3. Transportation and Energy Customers Look to Wharfedale’s SAP® Solutions with an Eye toward Cost Savings and Improved Operational Efficiencies
4. Sangui Bio Tech International Inc. - Over 500 Customers: Granulox Sales Ahead of Planning
5. Z Trim Holdings Grows Customer Base
6. BioInformatics LLC Announces New Market Report – Enhancing the Customer Experience: Insights and Life Science Supplier Rankings (13-002)
7. SoundConnect Announces New Not-For-Profit Customer in Smart Card Alliance
8. Rusterizer Gives Out Complimentary Rust Removers to First 100 Customers, My Cleaning Products Shares the Details
9. Puritan Medical Products Launches New Series to Tell Customer Stories
10. Veeva CRM Adds New Survey Functionality to Deepen Customer Understanding and Drive More Relevant Interactions
11. Centius – Partners with Engaged Nation– a Leading Gaming Industry Customer Loyalty Solution Provider to Help Maximize Customer Lifetime Value
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today ... (RGC), U.K. Biobank and GSK to generate genetic sequence data ... The initiative will enable researchers to gain valuable insights to ... wide range of serious and life threatening diseases. ... Genetic evidence ...
(Date:3/22/2017)... March 22, 2017 Oramed Pharmaceuticals Inc. ... www.oramed.com ), a clinical-stage pharmaceutical ... delivery systems, announced today that Dr. Miriam ... a presentation titled, "Oral Insulin for Diabetes Treatment: ... Healthtech Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference in ...
(Date:3/22/2017)... March 22, 2017   Boston Biomedical , an ... designed to target cancer stemness pathways, today announced its ... as Chief Executive Officer, effective April 24, 2017. ... J. Li , M.D., FACP, who has led Boston ... Under his leadership, Boston Biomedical has grown from a ...
(Date:3/22/2017)... (PRWEB) , ... March 21, 2017 , ... Benchworks ... Science Chief Executive Officer Forum on March 23-24 in San Diego. The event ... device and diagnostic industries. , Benchworks Vice President Christian Meyer will also participate ...
Breaking Biology Technology:
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
(Date:2/14/2017)... 14, 2017  Wake Forest Baptist Medical Center today ... chief executive officer (CEO). Freischlag joins the medical center ... McConnell , M.D., who last year announced that he ... Center, after leading it since 2008.   ... Wake Forest Baptist,s academic health system, which includes Wake ...
(Date:2/13/2017)... -- Former 9/11 Commission border counsel and Special Counsel ... of Identity Strategy Partners, LLP, today releases the ... Order: Protecting the Nation From Foreign Terrorist Entry Into ... President Trump,s ,Travel Ban, Executive Order gains more notoriety ... travel ban, it is important that our national discourse ...
Breaking Biology News(10 mins):